B. Wizner, “Similar benefits of 5-years simvastatin therapy among high cardiovascular risk patients, independently of baseline C-reactive protein concentration – The Heart Protection Study”, KardiolwPrakt, vol. 5, no. 1, pp. 35-37, Mar. 2011.